NWR Weekly Wrap ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­    ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  
View in browser
014fff0e-d808-e0aa-0213-b29ea5eed130
d2952fcd-676e-04c2-f6d2-5d736ee49fa3

Dicker Data (ASX: DDR) reported a strong FY25 performance, with gross revenue rising 14.9% to $3.9 billion and net operating profit before tax increasing 10.1% to $124.7 million, exceeding guidance. Growth was broad-based across software, endpoint solutions and advanced infrastructure, supported by subscription momentum, the Windows 10 refresh cycle and increasing AI-related activity. A fully franked final dividend of 11.5cps was declared, taking total FY25 dividends to 44.5cps, as the Company maintains solid operational and financial momentum heading into FY26.

 

Wagners (ASX: WGN) delivered H1 FY26 revenue up 12% to $251.7 million with Operating EBIT rising 72% to $35.0 million, exceeding guidance. Growth was driven by a 21% uplift in Construction Materials and a 36% increase in Composite Fibre Technologies, reflecting solid demand and margin expansion. With NPAT up 70% and a strengthened balance sheet following a $30 million capital raise, Wagners upgraded full-year FY26 Operating EBIT guidance to $62–66 million, underscoring continued momentum across the business.

 

Appen (ASX: APX) reported a return to growth in FY25, with revenue rising 4.5% to $230.8 million and underlying EBITDA (before FX) increasing 251% to $12.2 million, supported by margin expansion and operational efficiencies. Appen China delivered standout performance, up 75% on strong LLM-related demand, while the Global division finished the year with strong Q4 momentum. The Company guided to FY26 revenue of $270–$300 million and an underlying EBITDA margin of ~5–10%, reflecting confidence in continued AI-driven growth.

 

Acusensus (ASX: ACE) delivered a strong 1H FY26 result, with revenue up 40% to $40.3 million, underpinned by significant international growth and major contract wins in the US, New Zealand and Western Australia. The Company also expanded its WA fixed site enforcement agreement, adding an expected $11.2 million in incremental contract value. With a strengthened balance sheet, new debt facility and reaffirmed FY26 guidance, Acusensus enters the second half well positioned to capitalise on a growing global pipeline.

 

Saluda Medical (ASX: SLD) reported strong H1 FY26 momentum, delivering global revenue of US$39.4 million, up 17% on the prior corresponding period, underpinned by growth in US active implanting physicians and a 27% lift in international revenue. Gross margin expanded to 49.4%, ahead of IPO forecasts, with cash of US$151.4 million at period end. The Company reaffirmed its upgraded FY26 revenue guidance of US$85 million and remains on track to exceed key IPO prospectus financial metrics as it scales its commercial footprint.

 

Bioxyne (ASX: BXN) upgraded its FY26 adjusted EBITDA guidance to $16.5 million – $19.0 million, from previous range $11.5 million – $13.5 million. The adjusted EBITDA for H1 FY26 reached $8.3 million, representing a substantial increase from $3.7 million in the prior corresponding period (pcp). FY26 revenue guidance remains unchanged at $65 million–$75 million, with H1 FY26 revenue of $31.3 million compared to $12.6 million in the pcp. Covered by SmallCaps. Covered by SmallCaps.

 

Recharge Metals (ASX: REC) acquired the Sunset Well Gold Project, in the highly prospective Leonora gold district of WA. Positioned in a well-established mining region, Sunset Well is an advanced exploration asset centred on the Prospero Deposit. The project hosts a near-surface gold resource of 94,500 ounces, which remains open at depth and along strike, with no drilling undertaken since the 1990s. The wider tenement package also offers significant brownfields and greenfields exploration upside, supported by multiple high-grade historical drill intersections. Covered by Small Caps, mining.com.au, MiningNews, & ShareCafe.

 

Energy World Corporation (ASX: EWC) reported a transformational half-year marked by the elimination of all borrowings through a US$434m debt conversion, net tangible assets strengthened by 80% to 18.83 cents per share and advancing funding discussions for its Philippines LNG and power project.

 

Veteran investment analyst and journalist Tim Boreham cast his eye over the biotech sector for a Stockhead Health & Biotech Investor Guide of stocks to watch, with a list that includes  Avecho Biotechnology (ASX: AVE), Chimeric Therapeutics (ASX: CHM), CurveBeam AI (ASX: CVB), Neurotech International (ASX: NTI), PainChek (ASX: PCK), Radiopharm Theranostics (ASX: RAD), and ReNerve (ASX: RNV).

NWR Critical Minerals Webinar

NWR Critical Minerals March 5 2026

NWR Communications will host a Critical Minerals webinar on Tuesday, 5 March 2026 from 2pm AEDT featuring EQ Resources (ASX: EQR), IRIS Metals (ASX: IR1), Locksley Resources (ASX: LKY), Perpetual Resources (ASX: PEC) and Krakatoa Resources (ASX: KTA).

 

Click here to register for the free event.

NWR Investor Lunch

Screenshot 2026-02-26 160420

NWR Communications will host an investor lunch in Perth, bringing together ASX-listed companies positioned across the evolving energy landscape.

 

The session will feature presentations from Equus Energy, Hazer Group, NH3 Clean Energy and Sparc Technologies, followed by a discussion moderated by Declan Bonnick, Research Analyst at Euroz Securities.

 

📅 11 March 2026

📍 Parmelia Hilton Perth

🕛 12:00pm AWST

 

Click here to register for the event.

464b3264-700d-c512-d21d-1015cfbda0fa

Aurum Resources (ASX: AUE) rated BUY by Petra Capital with a $1.84 price target, implying ~149% upside to the current share price of $0.74, with a referenced spot valuation of $3.08 per share. Petra’s updated modelling reflects a significant step-up at Boundiali, lifting assumed plant throughput by 100% to 6Mtpa and increasing production by 78% to 190kozpa ahead of the PFS due this quarter. Longer term, the company is now targeting a group production profile of 450koz per annum within five years, driven by an optimised Boundiali hub and the development of a second hub at Napié.

1d8e370b-b352-ca8f-385a-25e59f5d215f

METALS, MINING AND ENERGY

 

Sunshine Metals (ASX: SHN) reported a standout drill result from its Liontown deposit in Queensland, with a 1m interval returning a remarkable 136g/t gold and 9,960g/t silver. The results sit within a broader 30-metre zone grading 6.68g/t gold and 528g/t silver, and adds to a growing string of high-grade hits that are reshaping the project's precious metals profile. Covered by Mining.com.au & Australian Resources & Investment.

 

Aurum Resources’ (ASX: AUE) Boundiali Project Mineral Resource increased to 3Moz gold with  Indicated Resources up 49% to 1.37Moz. This high-confidence growth provides a strong foundation for Boundiali’s upcoming PFS, cementing the project's status as a premier, large-scale West African gold asset. Aurum’s total group MRE now at 3.9Moz including the Napié deposit, with a Napié MRE update due this quarter. Covered by Proactive and MiningNews.net.

 

Further high-grade copper and silver results have been announced from drilling at Midas Minerals’ (ASX: MM1) Spaatzu Prospect at the Otavi Copper Project in Namibia. The Spaatzu Prospect represents a significant shallow copper-silver discovery, with mineralisation appearing to be widespread and exhibiting higher grade structurally controlled zones and lower-grade stratabound mineralisation styles. The company is working to complete a MRE for Spaatzu in late 2026 to complement the initial T-13 MRE expected to be reported this quarter.

 

Evergold Minerals (ASX: EG1) commenced a high-resolution ground gravity survey across the Mt Monger Gold Project in WA, designed to refine the shape and depth of a dense, interpreted gold system identified through recent geochemical and mineralogical work.  Covered by Market Bull.  It also completed the acquisition of the project.  Covered by Market Bull.

 

Locksley Resources (ASX: LKY) commenced diamond drilling at the Desert Antimony Mine within the Mojave Project in California, with the diamond drill rig now onsite and operational. The maiden drilling program is focused on testing extensions of known high-grade stibnite mineralisation beneath the historical mine workings. Covered by Stockhead, Discovery Alert & Courier Mail

 

EQ Resources (ASX: EQR) announced an agreement with Traxys Europe S.A. for a three-year €15 million pre-payment facility including a five-year commercial agreement with Traxys for 3,500 tonnes of WO3 produced from its Barruecopardo Mine in Spain. The value of this Commercial Agreement is approximately A$678 million, based on Fastmarket Tungsten APT 88.5% WO3 CIF Rotterdam.

 

BMG Resources (ASX: BMG) strengthened its development capability at the 100%-owned Abercromby Gold Project in WA with the appointment of Gareth McArthur as General Manager Project Development, a 25-year mining executive with senior experience at Rio Tinto, as BMG prepares for a 10,000m diamond drilling campaign to upgrade its 518,000oz gold resource and finalise a Q1 scoping study assessing open pit and underground scenarios for Abercromby. Covered by The West Australian.

 

Raptor Metals (ASX: RAP) completed an additional 10 HQ diamond drill holes, bringing the total completed to 12 of the planned 15 HQ holes at the Chester Project in New Brunswick, Canada. The 2,200m drilling program also includes three planned metallurgical holes (PQ), with completion of the remaining drilling expected within the next two weeks. This update builds on encouraging initial results and reflects ongoing progress in RAP’s systematic exploration strategy. Covered by Proactive Investors.

 

American Tungsten & Antimony (ASX: AT4) confirmed a larger than anticipated tungsten system at its 100%-owned Dutch Mountain Project in Utah following a sampling program, with mineralisation open in all directions. Sampling highlighted scale potential around the historic Fraction Lode Mine, the last active tungsten producer in the US in 2017 with reported head grades of 1.7% WO3. Dutch Mountain is underpinned by the only fully permitted tungsten processing facility in the Clifton Mining District, allowing AT4 to fast-track early production studies. Managing Director Andre Booyzen met with US Senator John Curtis to discuss domestic critical mineral security, while drilling at Antimony Canyon advances, with assays pending. Covered by Stockhead.

 

Kali Metals (ASX: KM1) signed a binding agreement to acquire SQM Australia’s 30% equity interest in the DOM’s Hill and Pear Creek Project in the Pilbara Region of WA. The transaction consolidates Kali’s Pilbara portfolio and provides the foundation for precious and base metal exploration as a 100% owner of these projects.

 

Charger Metals (ASX: CHR) reported further drilling assay results from its 100%-owned Lake Johnston Lithium and Gold Project, confirming the very high-grade nature of the Xmas Gold Discovery. Outstanding intercepts at Xmas including: 3m @ 18.0 g/t Au & 9.15 g/t Ag from 135m, including 1m @ 41.5 g/t Au & 26.5 g/t Ag and at the Richard Gold Prospect, split  7m @ 1.24 g/t Au from 60m, including 3m @ 2.12 g/t Au.

 

Everest Metals (ASX: EMC) submitted an International Patent Application under the Patent Cooperation Treaty for its unique Direct Rubidium Extraction process, utilising pegmatite ore from its Mt Edon Critical Minerals Project in Western Australia. The  application builds on ongoing collaborative research and testwork with Edith Cowan University’s Mineral Recovery Research Centre. Covered by Stockhead.

 

Native Mineral Resources (ASX: NMR) reported high-grade gold results from drilling at Podosky, part of its joint venture with Haoma Mining over the Ravenswood Gold Project in Qld. Results included 14m @ 8.21g/t Au from 15m including 6m @ 19.21g/t Au from 20m and 1m @ 51.71g/t Au from 24m. NMR plans to haul material from Ravenswood to its Blackjack Operations for processing.

 

Cleanteq Water (ASX: CNQ) announced it has successfully completed the performance testing and commissioning of the CLEAN-IX® UColumn Uranium Processing Plant for Heathgate Resources as part of its uranium operations in South Australia. The contract, executed in September 2023, covered the delivery of a CLEAN-IX® U-Column system and associated equipment based on Clean TeQ’s proprietary Moving Bed Ion Exchange (MBIX) technology.

 

INDUSTRIALS

 

LaserBond (ASX: LBL) reported revenue of $23.0 million for 1H FY26, representing growth of 13.4% on the prior corresponding period ($20.3 million) and in line with 2H FY25 performance ($23.2 million). Gross profit of $12.4 million delivered a healthy margin of 53.9%. A strong order book, ongoing innovation investment, and effective management of material availability support confidence for the remainder of FY26.

 

Babylon Pump & Power (ASX: BPP) reported H1 FY26 revenue of $17.6m and $3.0m underlying EBITDA, delivering $4.2m in operating cash flow as the Company completed transformational rental acquisitions, secured a new multi-year Newmont contract and streamlined its portfolio to focus on higher-margin water management services.

 

BPH Global (ASX: BP8), a leading seaweed trading and product innovation company, announced aggregate sales for its first nine months of trading of approximately A$2.36 million, reflecting continued establishment and scaling of BPH’s Indonesian seaweed trading platform. The Company raised A$1m in a share placement with $600,000 to expand its Indonesian seaweed trading operations. This follows on from the recent (Memorandum of Understanding / MoU) with Badan Riset dan Inovasi Nasional (BRIN), Indonesia’s National Research and Innovation Agency.


Etherstack plc (ASX: ESK) reported FY25 revenue of US$10.1 million, up 70% on the prior year, delivering record annual revenue and EBITDA of US$2.0 million following a US$3.2 million turnaround. Growth was driven by major contract wins including a US$20 million+ AT&T FirstNet agreement and a £14.2 million UK Home Office deal, supporting a step-change in recurring support revenues, which increased 62% to US$3.7 million. The Company ended the period with US$2.3 million in cash, positioning Etherstack for forecast FY26 revenue of US$16.2–17.5 million.

 

CONSUMER

 

Lark Distilling (ASX: LRK) reported H1 FY26 net sales of $8.7 million, up 10% on the prior corresponding period, driven by 18% growth in whisky sales and strength across direct-to-consumer, global travel retail and export channels. The Company ended the half with $18.3 million in cash and no debt, following completion of the Pontville Distillery redevelopment, positioning LARK for its global portfolio launch in H2 FY26.


Cettire (ASX: CTT) delivered adjusted EBITDA of $8.7 million in H1 FY26, marking a significant $20.5 million half-on-half improvement as the Company leveraged its flexible business model to drive stronger profitability. While sales revenue of $382.8 million was broadly stable year-on-year, performance was underpinned by 13% growth outside the US and increasing contribution from repeat customers, now representing 69% of gross revenue. With $61.4 million in cash and no debt, Cettire remains well positioned to adapt to market conditions and pursue profitable global growth into FY26.

 

TECHNOLOGY

 

RAS Technology (ASX: RTH) reported revenue for the half year ended 31 December 2025 of $13.9 million, up 38% compared to the pcp, supported by growth across all operating divisions. ARR increased to $24.6 million, representing 34% growth year-on-year, driven by new contracts, expansion of the MTS and strong UK performance.


PlaySide Studios (ASX: PLY) delivered a strong turnaround in its H1 FY26 result, reporting EBITDA of $9.5m and NPAT of $7.9m, alongside operating cash flow of $5.6m, as the Company completed its restructure and streamlined its cost base. MOUSE: P.I. for Hire continues to build momentum with wishlists rising 20% to 1.2m, ranking 18th on Steam, with launch set for 16 April. With strengthened publishing initiatives and annualised cost savings of ~$7m, PlaySide expects FY26 revenue to exceed FY25 with lower operating costs.

 

BIOTECH

 

Neurotech International (ASX: NTI) reported a significant milestone in the development of its lead cannabinoid therapy NTI164. A rigorous 90-day GLP toxicology study in Beagle dogs showed the drug was well tolerated at doses up to ten times the highest human dose evaluated to date, with no mortality, dose-limiting toxicities, or clinically meaningful adverse effects observed. Covered by The Australian.

 

Radiopharm Theranostics (ASX: RAD) announced dosing of the first patient in its First-In-Human (FIH) Phase 1/2a clinical trial of 177Lu-Betabart (RV-01). The dose escalation and expansion trial is designed to evaluate the safety, biodistribution and radiation dosimetry of 177Lu-BetaBart, along with its preliminary anti-tumor activity. 

 

ReNerve (ASX: RNV) reported 60.2% sales growth in H1 FY26 compared to the

corresponding period in FY25, reflecting growing adoption of the NervAlign® Nerve Cuff in the

United States and increasing surgeon utilisation.


Imricor Medical Systems (ASX: IMR) delivered a defining FY25, highlighted by CE Mark approvals under the EU MDR for its second-generation platform, including NorthStar®, and the landmark first-in-human ischemic VT ablation under real-time MRI guidance, commencing the VISABL-VT trial. The Company significantly expanded its European pipeline from 7 to 40 sites and progressed U.S. FDA clearances, ending the year with US$40.8 million in cash to support continued commercial and regulatory momentum.

 

CORPORATE NEWS

 

Frontier Energy (ASX: FHE) appointed Jamie Cullen as its Executive Chairman as it continues to advance its Waroona Renewable Energy Project in WA. Mr Cullen is the former Chief Executive Officer of Pacific Energy, which he oversaw to become Australia’s largest remote energy specialist, with approximately 1GW of contracted power generation under long-term power purchase agreements.

 

Kairos Minerals (ASX: KAI) announced a proposed 15-for-1 Share Consolidation and name change to “Pilbara Gold Limited” to better reflect its development strategy for the 1.4Moz Mt York Gold Project in WA. An extraordinary general meeting will be held on 30 March 2026. 

 

Richmond Vanadium Technology (ASX: RVT) appointed Joanne Bergamin as Advisory Board Member - Communications & Stakeholder Engagement. With her extensive 

experience across Queensland’s critical minerals sector, Joanne will further strengthen RVT’s engagement with government and regional stakeholders. 


Tungsten Mining (ASX: TGN) is pursuing a new U.S. listing to accelerate development of its globally significant tungsten portfolio. The company is targeting a listing on the Nasdaq or New York Stock Exchange, intended to strengthen its engagement with U.S. government agencies and defence, whilst expanding its investor base.

d7cefbb6-7616-345e-7780-13366b553fdc

Metro Mining Limited (ASX:MMI), invites shareholders to a Webinar Presentation by Chief Executive Officer and Managing Director, Simon Wensley, and Chief Financial Officer, Nathan Quinlin, covering a discussion on the Company’s 2025 Annual Results.

When: Friday, 27 February 2026 

Time: 2.00 AEDT / 1.00pm AEST 

 

Register: https://us02web.zoom.us/webinar/register/WN_XS04iA66Tw6OQOTLYJFenw

 

American Tungsten & Antimony (ASX:AT4) AT4 Tungsten Strategy - Investor Webinar

When: Friday 27 February 2026

Time: 11:00am AEDT / 8:00am AWST

 

Register: https://us02web.zoom.us/webinar/register/WN_lv5MyQRMQP6PMyyaFBqrnQ

2bd5880e-8827-b5ce-6048-53977a37b835

Many Peaks Minerals (ASX: MPK) Maiden MRE for Ferké in H1 2026. Covered by Mining.com.au.

 

Equus Energy (ASX: EQU) Covered by The Australian.

 

Stockhead has released its 2026 Biotech investor guide highlighting 25 pioneering Australian health and biotech companies. The guide highlights Neurotech International (ASX: NTI), who are developing therapies to treat common and rare neurodevelopment disorders in children. Also featured is Chimeric Therapeutics’ (ASX: CHM) leading cell therapy asset CDH-17, which is targeting colorectal cancer and neuroendocrine tumours.

 

Strata Minerals (ASX: SMX) was featured in a Stockhead article by Barry Fitzgerald titled: “WA gold juniors eyeing the big leagues as high prices promise rivers of cash”.

 

Falcon Metals (ASX) and Magmatic Resources (ASX: MAG) were highlighted in a feature article by Australian Resources and Investment, discussing how the recent RIU Explorers Conference showcased the growth in exploration activity across Australia on the back of the surging gold price.

9360579f-5f37-12bd-5e32-0b822a6998a0

Recharge Metals (ASX: REC) Acquisition of the Sunset Well Gold Project Presentation

 

Koba Resources (ASX: KOB) RIU Explorers Conference Presentation replay

 

Sunshine Metals (ASX: SHN) Investor Presentation Townsville Industry Breakfast

 

Bioxyne (ASX: BXN) H1 FY2026 Results Presentation

 

Locksley Resources (ASX: LKY) Investor Presentation Webinar replay

 

LaserBond (ASX: LBL) H1 FY2026 Results Presentation

 

RAS Technology (ASX: RTH) H1 FY2026 Results Presentation

 

Decidr AI Industries (ASX: DAI) Investor Presentation

 

Dicker Data (ASX: DDR) FY25 Results Presentation

 

Wagners (ASX: WGN) H1 FY26 Results Presentation

 

Appen (ASX: APX) FY25 Results Presentation

 

Imricor Medical Systems (ASX: IMR) FY25 Results Investor Presentation

 

Acusensus (ASX: ACE) Half Year FY26 Results Presentation


Playside Studios (ASX: PLY) 1H FY26 Results Presentation

08d61125-922d-f279-49d0-ba04b9faa6bb
thumbnailify.com_youtube_thumbnail_Full_HD_2026-02-26_04-51-57
Many Peaks Minerals (ASX: MPK) Managing Director Travis Schwertfeger joined Mining.com.au’s Shae Russell at the RIU Explorers Conference in Fremantle to discuss momentum building at the Ferké Gold Project in Côte d’Ivoire.
thumbnailify.com_youtube_thumbnail_Full_HD_2026-02-26_04-52-52
Alligator Energy’s (ASX: AGE) CEO Andrea Marsland-Smith caught up with Mining.com.au and Small Caps at last week’s RIU Explorers Conference outlining the progress at the Samphire Uranium Project. Commissioning has now been completed, with preconditioning of the well pattern underway ahead of uranium extraction.
thumbnailify.com_youtube_thumbnail_Full_HD_2026-02-26_04-53-02

Ark Mines (ASX: AHK) Managing Director Ben Emery spoke to Mining.com.au about the rare earths processing trial MOU recently signed and activities ahead at the Sandy Mitchell Project.

thumbnailify.com_youtube_thumbnail_Full_HD_2026-02-26_04-54-13
Falcon Metals (ASX: FAL) Managing Director Tim Markwell spoke to David Tasker about the drilling success at Blue Moon and the exploration plans for 2026.
thumbnailify.com_youtube_thumbnail_Full_HD_2026-02-26_04-54-29
Vita Resources (ASX: VTA) Non-Executive Chairman Gavin Rutherford spoke to David Tasker about the potential of Vita’s ICE Copper-Gold Project in Canada and its Ninnis Gold Project in WA.
thumbnailify.com_youtube_thumbnail_Full_HD_2026-02-26_04-54-45
Koba Resources (ASX: KOB) Managing Director & CEO Ben Vallerine spoke with David Tasker from The Pick Magazine about the company’s projects across Queensland and South Australia and why both regions are strategically important to Koba’s growth plans.
thumbnailify.com_youtube_thumbnail_Full_HD_2026-02-26_04-55-00
In this interview, Locksley Resources (ASX: LKY) Managing Director & CEO Kerrie Matthews outlines why the commencement of diamond drilling at the Desert Antimony Mine marks a defining execution milestone as the company moves into subsurface testing of high grade antimony structures.
thumbnailify.com_youtube_thumbnail_Full_HD_2026-02-26_04-55-17
Kalamazoo Resources (ASX: KZR) Chair Luke Reinehr spoke to Shae Russell from Mining.com.au from the floor at RIU Explorers conference.
thumbnailify.com_youtube_thumbnail_Full_HD_2026-02-26_04-55-33
Lincoln Minerals (ASX: LML) CEO Chris Wilcox held an investor webinar this week - a replay is available.
thumbnailify.com_youtube_thumbnail_Full_HD_2026-02-26_04-55-48
ECS Botanics (ASX: ECS) Managing Director Nan-Maree Schoerie joined The Market Bull to discuss the company's recent partnership with a German distributor as it enters Europe’s largest cannabis market.

NWR Communications, Level 6, 350 Collins Street, Melbourne, VIC 3000

Unsubscribe Manage preferences